home / stock / alvo / alvo news

ALVO News and Press, Alvotech From 01/06/26

Stock Information
Company Name: Alvotech
Stock Symbol: ALVO
Market: NASDAQ
Website: alvotech.com
Menu
ALVO ALVO Quote ALVO Short ALVO News ALVO Articles ALVO Message Board
Get ALVO Alerts

News, Short Squeeze, Breakout and More Instantly...
ALVO - Alvotech announces planned CEO succession and leadership transition

 - R ó bert Wessman to continue serving as Executive Chairman in full-time capacity - Lisa Graver appointed Chief Executive Officer REYKJAVIK, Iceland, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotechnology company specializing in the development and m...
ALVO - Alvotech Secures Term Loan Facility of USD 100 Million

USD 100 million senior term loan facility with a 2-year maturity Strengthens liquidity to support execution across Alvotech’s R&D pipeline and global product launches through 2026 Led by GoldenTree Asset Management REYKJAVIK, Iceland, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Alvo...

ALVO - Teva Pharmaceuticals: Why It's Time To Cash Out (Rating Downgrade)

2025-12-23 18:08:28 ET The investment thesis I laid out in my first article about Teva Pharmaceutical ( TEVA ) has finally played out. At the time of that article, TEVA was fluctuating around $16.50-$17.00 and is now above $31.50. ... Read the full article on Seeking A...

ALVO - Alvotech announces European launch of biosimilar to Simponi

2025-12-22 02:21:18 ET More on Alvotech Alvotech (ALVO) Discusses Launch of $125 Million Commercial Bond Offering and Business Update Transcript Alvotech (ALVO) Q3 2025 Earnings Call Transcript Alvotech 2025 Q3 - Results - Earnings Call Presentation Alvotech,...
ALVO - Alvotech announces European launch of first-in-market biosimilar to Simponi® (golimumab) globally by partner Advanz Pharma

Introduction of AVT05 supported by NHS England tender award in the United Kingdom REYKJAVIK, Iceland, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, toda...

ALVO - Alvotech, Teva reach settlement with Regeneron over Eylea biosimilar AVT06 in U.S.

2025-12-19 05:08:31 ET More on Teva Pharmaceutical, Alvotech, etc. Regeneron Pharmaceuticals, Inc. (REGN) Discusses Lynozyfic Development Strategy and Pipeline Opportunities in Multiple Myeloma - Slideshow Alvotech (ALVO) Discusses Launch of $125 Million Commercial Bond Offe...

ALVO - Alvotech and Teva Secure U.S. Settlement Date for AVT06, a Proposed Biosimilar to Eylea®

REYKJAVIK, Iceland and TEL AVIV, Israel and PARSIPPANY, N.J., Dec. 19, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Teva Pharmaceuticals, a U.S. affiliate of Teva Phar...
ALVO - Alvotech to raise $100M via convertible bonds, provides 2026 forecast

2025-12-17 05:31:22 ET More on Alvotech Alvotech (ALVO) Discusses Launch of $125 Million Commercial Bond Offering and Business Update Transcript Alvotech (ALVO) Q3 2025 Earnings Call Transcript Alvotech 2025 Q3 - Results - Earnings Call Presentation Alvotech&...

ALVO - FIS Christian Stock Fund declares annual distribution of $0.2596

2025-12-16 15:32:23 ET More on Sodexo S.A. (SDXAY) Shareholder/Analyst Call - Slideshow Generac: Lagging Among Industrials, Banking On AI Demand Alvotech (ALVO) Discusses Launch of $125 Million Commercial Bond Offering and Business Update Transcript Texas AG ...

ALVO - Alvotech (ALVO) Discusses Launch of $125 Million Commercial Bond Offering and Business Update Transcript

2025-12-16 15:19:05 ET Alvotech (ALVO) Discusses Launch of $125 Million Commercial Bond Offering and Business Update December 16, 2025 12:00 PM EST... Read the full article on Seeking Alpha For further details see: Alvotech (ALVO) Discusses Launch of $125 Million Commercial ...
Previous 10 Next 10